Arif v. United States

CourtDistrict Court, D. New Hampshire
DecidedFebruary 18, 2020
Docket1:19-cv-00586
StatusUnknown

This text of Arif v. United States (Arif v. United States) is published on Counsel Stack Legal Research, covering District Court, D. New Hampshire primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Arif v. United States, (D.N.H. 2020).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW HAMPSHIRE

Mustafa Hassan Arif

v. Case No. 19-cv-586-LM Opinion No. 2020 DNH 023 United States

O R D E R On October 11, 2016, Mustafa Hassan Arif pleaded guilty to one count of wire fraud in violation of 18 U.S.C. § 1343, and on May 26, 2017, this court sentenced him to serve 72 months in prison. See United States v. Mustafa Hassan Arif, 15-cr-057-LM (D.N.H. May 26, 2017) (“Arif I”). Arif appealed his conviction and sentence, and on July 19, 2018, the First Circuit affirmed both. See id. at doc. nos. 156 and 157. He now moves pursuant to 28 U.S.C. § 2255 to vacate his sentence, alleging prosecutorial misconduct and six claims of ineffective assistance of counsel. The government objects.

STANDARD OF REVIEW Under § 2255, a federal prisoner may ask the court to vacate, set aside, or correct a sentence that “was imposed in violation of the Constitution or laws of the United States.” 28 U.S.C. § 2255(a). The burden of proof is on the petitioner. Wilder v. United States, 806 F.3d 653, 658 (1st Cir. 2015). Once a prisoner requests relief under § 2255 the district court must grant an evidentiary hearing unless “the motion and the files and records of the case conclusively show that the prisoner is entitled to no relief.” 28 U.S.C. § 2255(b). Thus, an evidentiary hearing is not necessary when “a § 2255 motion

(1) is inadequate on its face, or (2) although facially adequate is conclusively refuted as to the alleged facts by the files and records of the case.” Morgan v. Hogan, 494 F.2d 1220, 1222 (1st Cir. 1974).

BACKGROUND I. Factual Background Arif owned and operated over 1,500 commercial websites while living in Lahore, Pakistan. On most of those sites, he sold drugs which he claimed treated or cured various diseases and conditions. His internet reach spanned across the globe far

beyond the borders of Pakistan. The results were successful: he generated $12 million, most of which came from customers in the United States. His endeavors quickly caught the eye of the United States Government for several reasons. First, the websites selling drugs had misleading mail-forwarding addresses. For example, a website marketed to Germans had a German address. Other websites had mail forwarding addresses in England, Scotland, Australia, and many other countries. This strategy was illegal because every website and drug originated in Pakistan. Second, information on the websites about the drugs themselves contained gross misrepresentations. For example, Arif falsely claimed that some of the drugs had a “cure rate for

90% of subjects” or had a “92% effect on the disease without a single side effect.” In most cases, Arif never tested the drugs nor backed up his claims with reputable evidence. Arif’s websites also included false testimonials from customers as to the drugs’ effectiveness. Third, Arif generated $9 million in revenue from United States customers. He used a third-party credit card processor and authorized retailer named CCNow to transfer his revenue. CCNow used JP Morgan Chase to wire Arif’s proceeds from its bank account in Minnesota to his various bank accounts in Pakistan and the United Kingdom.

II. Procedural Background On April 8, 2015, a federal grand jury indicted Arif on one count of wire fraud and aiding and abetting the same under 18 U.S.C. § 1343 and two counts of misbranding drugs in interstate commerce under 21 U.S.C. §§ 331(a), 333(a)(2), and 352(a). A grand jury returned a superseding indictment on September 9, 2015, which increased the misbranding drug counts to a total of four. On October 11, 2016, Arif entered a conditional plea of guilty to one count of wire fraud under 18 U.S.C. § 1343. He subsequently appealed both his sentence and conviction, and the First Circuit affirmed.

Arif filed the current § 2255 petition on June 3, 2019, alleging prosecutorial misconduct and six claims of ineffective assistance of counsel. The government responds that the court can resolve the majority of Arif’s claims without an evidentiary hearing. It concedes, however, that certain claims require further factual development and requests that the court schedule an evidentiary hearing. Arif counters that an evidentiary hearing is not necessary but, to the extent the court disagrees, he requests that the court appoint him counsel due to his “strained financial condition” and waive his appearance at the hearing. Doc. no. 7 at 3.

DISCUSSION Arif asserts seven claims in his § 2255 petition: • the government breached its promise that Arif would be prosecuted for only two misbranding of drug charges (and not wire fraud) in exchange for him providing information on CCNow (Claim 1); • ineffective assistance of counsel based on his attorneys’ failure to obtain the government’s promise in writing or to bring it to the court’s attention (Claim 2);

• ineffective assistance of counsel based on his attorneys’ failure to assert the defense of improper venue (Claim 3);

• ineffective assistance of trial and appellate counsel based on their failure to argue that the wire fraud statute did not apply to the allegations of false advertising of non- prescription drugs (Claim 4);

• ineffective assistance of counsel based on his attorneys’ failure to assert a defense under the Speedy Trial Act, 18 U.S.C. § 3161, et seq. (Claim 5);

• ineffective assistance of counsel based on his attorneys’ failure to advise him that the FDA could not investigate false advertising of non-prescription drugs and that the FDA’s presence at grand jury proceedings violated his due process rights (Claim 6); and

• ineffective assistance of counsel based on his appellate counsel’s failure to pursue the argument that the fact that Arif informed his customers that his products were not FDA- approved negated any intent to defraud, and that the government could not approve a charge of wire fraud without FTC certification (Claim 7).

The court first addresses Arif’s ineffective assistance of counsel arguments in Claims 3-7.

I. Claims 3-7 Claims 3-7 are based on the alleged ineffectiveness of Arif’s trial and/or appellate counsel. When a § 2255 petition is based on ineffective assistance of counsel, the petitioner “must demonstrate both: (1) that ‘counsel’s performance was deficient,’ meaning that ‘counsel made errors so serious that counsel was not functioning as the “counsel” guaranteed the defendant by the Sixth Amendment’; and (2) ‘that the deficient performance prejudiced the defense.’” United States v. Valerio, 676 F.3d 237, 246 (1st Cir. 2012) (quoting Strickland v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Strickland v. Washington
466 U.S. 668 (Supreme Court, 1984)
Hill v. Lockhart
474 U.S. 52 (Supreme Court, 1985)
United States v. Rodriguez-Moreno
526 U.S. 275 (Supreme Court, 1999)
Ferrara v. United States
456 F.3d 278 (First Circuit, 2006)
George Moran v. Marvin Hogan
494 F.2d 1220 (First Circuit, 1974)
United States v. Valerio
676 F.3d 237 (First Circuit, 2012)
United States v. Don H. Pace
314 F.3d 344 (Ninth Circuit, 2002)
United States v. Foley
783 F.3d 7 (First Circuit, 2015)
Wilder v. United States
806 F.3d 653 (First Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
Arif v. United States, Counsel Stack Legal Research, https://law.counselstack.com/opinion/arif-v-united-states-nhd-2020.